Soligenix enters ATM equity facility with Rodman & Renshaw for up to $3.45M

SOLIGENIX, INC.

Up to $3,450,000 of common stock may be sold at market prices through Rodman & Renshaw as sales agent.
Commission of 3.0% of gross proceeds; facility expires December 15, 2026.
Company can sell shares at its discretion; no minimum obligation to sell.
Sales will be made via an at-the-market offering under existing shelf registration statement (File No. 333-274265).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.